Skip to main content

Ethicon Prolene Hernia Patch Lawsuit Filed in New Jersey

Ethicon Prolene Hernia Patch Lawsuit Filed in New Jersey

Ethicon Prolene Hernia Patch Lawsuit Filed in New Jersey

Introduction

A lawsuit filed by a plaintiff in the New Jersey Supreme Court against Ethicon Prolene manufacturer Johnson & Johnson and its subsidiary Ethicon, alleges that the hernia patch led to a series of complications ever since it was implanted.

The complaint filed by the plaintiff on July 5 indicates that he was implanted with a 4.5 cm by 10 cm patch of the Ethicon Prolene Hernia System February 2007, for correcting a right inguinal hernia. Surgeons discovered that the Prolene Hernia Mesh got attached to the inguinal canal floor and encircled his spermatic cord as well as the iliac inguinal nerve. The condition worsened as he developed severe pain, inflammation, nausea, extreme weight loss, and the need for additional surgeries. Eventually, he underwent revision surgery to remove the hernia patch in December 2009. The lawsuit states Johnson & Johnson and Ethicon did not conduct proper clinical trials for their Ethicon multi-layered hernia mesh product line, which includes the Prolene Hernia System, as well as the recalled Physiomesh product.  

Hernia Mesh Lawsuits were consolidated in June 2017 for pretrial proceedings in the Northern District of Georgia as a part of a multidistrict litigation (MDL No. 2782; In Re: Ethicon Physiomesh Flexible Composite Hernia Mesh Products Liability Litigation) presided over by Judge Richard Story.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!